E Fund Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

E Fund Management’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,463	Closed	-$76K	–	325
2023 Q3	$76K	Buy	11,463 +939	+9%	+$7.8K	0.01%	288
2023 Q2	$95K	Buy	+10,524	New	+$92.8K	0.01%	302
2023 Q1	–	Sell	-15,530	Closed	-$113K	–	356
2022 Q4	$113K	Buy	15,530 +5,318	+52%	+$39.5K	0.01%	325
2022 Q3	$79K	Buy	+10,212	New	+$86.7K	0.01%	331

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

E Fund Management's PNT Position: Q4 2023 in Review

E Fund Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 11,463 shares — an estimated $76K sold.

E Fund Management first reported a position in PNT in Q3 2022 and held it in 4 quarters. The position peaked at $113K in Q4 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

E Fund Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
E Fund Management sold 11,463 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $76K.
E Fund Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 4 quarters.
E Fund Management's POINT Biopharma Global Inc. Common Stock position peaked at $113K in Q4 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on E Fund Management's 13F filing for Q4 2023, filed 7 Feb 2024.